Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-03

Clinical Trial Update: Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of Hou Gu Mi Xi in patients with peptic ulcer disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hou Gu Mi Xi

Snippet

Sponsor: Jiangxi University of Traditional Chinese Medicine | Conditions: Peptic Ulcer Disease | NA | Status: COMPLETED